Mwandishi:
Mhariri:
ULY CLINIC
Dkt. Benjamin L, MD
17 Machi 2021 19:19:41
Gentamicin na ujauzito
Gentamicin hutumika sana kwenye matibabu ya magonjwa kwa mama mjamzito.Uhusiano wa dawa hii na kutokea kwa madhaifu ya kiuumbaji hayajaonekana bado licha ya kutumika sana
Ushauri dhidi ya matumizi kwa mama mjamzito
Hakuna (zipo chache) taarifa za binadamu- taarifa za wanyama zinaonyesha kuwepo hatari kidogo
Hakuna (zipo chache) taarifa za binadamu- taarifa za wanyama zinaonyesha kuwepo hatari kidogo ina maana gani?
Inawezekana kuwa hakuna taarifa za zoefu wa matumizi ya dawa hii au taarifa za binadamu wajawazito wachache waliotumia dawa hii zimeonyesha kutohusiana kuwa sumu kwa kichangawa tumboni kuweza kusababisha madhaifu ya uumbaji, ukuaji, viungo vya mwili, ufanyaji kazi wa viungo, tabia au kusababisha kifo endapo itatumika. Dawa haileti sumu kwenye uumbaji wa kijusi (kwenye dozi ambayo haikusababisha sumu kwa mama) kwenye jamii zote za wanyama waliofanyiwa tafiti kwenye dozi ambayo ni sawa au pungufu ya mara kumi ya ile ya binadamu, dozi inayotolewa kuendana na jumla ya eneo la mwili
Ushauri wa matumizi kwa mama anayenyonyesha
Inapatana na unyonyeshaji
Inapatana na unyonyeshaji ina maana gani?
Kiasi kidogo cha dawa hii kinawezekana kuingia kwenye maziwa ya mama, kiasi hiki hakina mashiko ya kusababisha sumu kwa kichanga anayenyonya. Dawa hii haitarajiwi kusababisha madhara kwa kichanga anayenyonya maziwa ya mama anayetumia dawa hii.
ONYO: Usitumie dawa yoyote bila ushauri wa daktari. Dawa zinaweza kuleta madhara mwilini na pia matumizi ya baadhi ya dawa pasipo ushauri na vipimo husababisha vimelea kuwa sugu dhidi ya dawa hiyo.
ULY clinic inakushauri kuwasiliana na daktari wako unapotaka kuchukua maamuzi yoyote yanayohusu afya yako.
Wasiliana na daktari/Mfamasia wa ULY clinic kwa ushauri na Tiba au kuandikiwa dawa kwa kupiga simu au Kubonyeza Pata tiba chini ya tovuti hii.
Imeboreshwa,
1 Julai 2023 17:21:36
Rejea za mada hii
1. Product information. Garamycin. Schering, 1997.
2. Mallie JP, et al. In utero aminoglycosides-induced nephrotoxicity in rat neonates. Kidney Int 1988;33:36–44.
3. Smaoui H, et al. Gentamicin administered during gestation alters glomerular basement membrane development. Antimicrob Agents Chemother 1993;37:1510–7.
4. Lelievre-Pegorier M, et al. Effect of fetal exposure to gentamicin on phosphate transport in young rat kidney. Am J Physiol 1993;265:F807–12.
5. Stahlmann R, et al. The developmental toxicity of three antimicrobial agents observed only in nonroutine animal studies. Reprod Toxicol 1997;11:1–7.
6. Percetto G, et al. Observations on the use of gentamicin in gynecology and obstetrics. Minerva Ginecol 1969;21:1–10.
7. von Kobyletzki D. Experimental Studies on the Transplacental Passage of Gentamicin. Presented at Fifth International Congress on Chemotherapy, Vienna, 1967.
8. von Koblyetzki D, et al. Pharmacokinetics of Gentamicin during Delivery. Antimicrobial Anticancer Chemotherapy. Proceedings of the Sixth International Congress on Chemotherapy, Tokyo, 1969;1:650–2.
9. Yoshioka H, et al. Placental transfer of gentamicin. J Pediatr 1972;80:121–3.
10. Garcia S, et al. Perinatal pharmacology of gentamicin. Clin Res 1972;20:252.
11. Daubenfeld O, et al. Transfer of gentamicin to the foetus and the amniotic fluid during a steady state in the mother. Arch Gynecol 1974;217:233–40.
12. Kauffman R, et al. Placental transfer and fetal urinary excretion of gentamicin during constant rate maternal infusion. Pediatr Res 1975;9:104–7.
13. Weinstein A, et al. Placental transfer of clindamycin and gentamicin in term pregnancy. Am J Obstet Gynecol 1976;124:688–91.
14. Creatsas G, et al. Ampicillin and gentamicin in the treatment of fetal intrauterine infections. J Perinat Med 1980;8:13–8.
15. Gilstrap LC III, et al. Antibiotic concentration in maternal blood, cord blood, and placental membranes in chorioamnionitis. Obstet Gynecol 1988;72:124–5.
16. Graham JM, et al. Gentamicin levels in pregnant women with pyelonephritis. Am J Perinatol 1994;11:40–41.
17. Regev RH, et al. Gentamicin serum concentrations in neonates born to gentamicin-treated mothers. Pediatr Infect Dis J 2000;19:890–1.
18. Barak J, et al. Transabdominal amnioinfusion of gentamicin: a pharmacokinetic study of maternal plasma and intraamniotic levels (abstract). Am J Obstet Gynecol 1997;176:S59.
19. Freeman D, et al. Amniotic fluid and maternal and cord serum levels of gentamicin afterintra-amniotic instillation in patients with premature rupture of the membranes. Am J Obstet Gynecol 1972;113:1138–41.
20. Hulton S-A, Kaplan BS. Renal dysplasia associated with in utero exposure to gentamicin and corticosteroids. Am J Med Genet 1995;58:91–3.
21. Wing DA, et al. A randomized trial of three antibiotic regimens for the treatment of pyelonephritis in pregnancy. Obstet Gynecol 1998;92:249–53.
22. Czeizel AE, et al. A teratological study of aminoglycoside antibiotic treatment during pregnancy. Scand J Infect Dis 2000;32:309–13.
23. L’Hommedieu CS, et al. Potentiation of magnesium sulfate-induced neuromuscular weakness by gentamicin, tobramycin, and amikacin. J Pediatr 1983;102:629–31.
24. Celiloglu M, et al. Gentamicin excretion and uptake from breast milk by nursing infants. Obstet Gynecol 1994;84:263–5.
25. Mann CF. Clindamycin and breast-feeding. Pediatrics 1980;66:1030–1.
26. Committee on Drugs, American Academy of Pediatrics. The transfer of drugs and other chemicals into human milk. Pediatrics 2001;108:776–89.